Acquired vancomycin resistance in clinically relevant pathogens.
about
Acquired inducible antimicrobial resistance in Gram-positive bacteriaMolecular basis of antibiotic multiresistance transfer in Staphylococcus aureusSolonamide B inhibits quorum sensing and reduces Staphylococcus aureus mediated killing of human neutrophilsBinaphthyl-anchored antibacterial tripeptide derivatives with hydrophobic C-terminal amino acid variations.The rise of the Enterococcus: beyond vancomycin resistance.Development of quorum-based anti-virulence therapeutics targeting Gram-negative bacterial pathogens.Vancomycin-Resistant Enterococci and Bacterial Community Structure following a Sewage Spill into an Aquatic Environment.Strained cyclophane natural products: macrocyclization at its limits.The cell wall architecture of Enterococcus faecium: from resistance to pathogenesis.Development of antivirulence compounds: a biochemical review.Identification of vancomycin interaction with Enterococcus faecalis within 30 min of interaction time using Raman spectroscopy.Verbascoside Alleviates Pneumococcal Pneumonia by Reducing Pneumolysin Oligomers.In vitro activity of the new multivalent glycopeptide-cephalosporin antibiotic TD-1792 against vancomycin-nonsusceptible Staphylococcus isolates.Biogenic tellurium nanorods as a novel antivirulence agent inhibiting pyoverdine production in Pseudomonas aeruginosa.Terrein is an inhibitor of quorum sensing and c-di-GMP in Pseudomonas aeruginosa: a connection between quorum sensing and c-di-GMP.
P2860
Q27027012-03340A7A-8E40-4144-BBA0-31FF1C2308DCQ27676045-C5971FE7-9CC1-464A-B0E7-A426F141B2E6Q28538518-D8EF2450-D96C-43D0-8841-25E62783D1D6Q36281200-DDF89F69-AC8C-4F0C-B991-8C9D428898ACQ36752156-BB1C3BC0-F2C6-4D05-A075-E1A8D79D28AFQ37139191-B959DD81-4034-4AA9-B3FA-6E87C48CDF6EQ37224121-7AB7EBFC-1143-4C77-92D0-F380A2E8D71BQ38021350-93C473E2-3905-4936-AF18-F748C38D3F1AQ38125495-437364E3-66DA-427D-9CD6-D331DDAB616BQ38293001-04D26DBC-FBE6-4524-AADF-2C4620D7CB69Q40672138-5A5D72E2-219B-478D-81FA-9ADC6CD216C7Q40858891-F654B19B-B365-4051-861F-302114006BADQ41837870-34D8D190-C31F-4CAC-B30D-00917E4169A0Q46845402-54328406-F4EB-45C5-AE62-5851331C751DQ55265092-DB7041B5-3E8B-40AD-B033-A83B2AD7A6A9
P2860
Acquired vancomycin resistance in clinically relevant pathogens.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Acquired vancomycin resistance in clinically relevant pathogens.
@en
Acquired vancomycin resistance in clinically relevant pathogens.
@nl
type
label
Acquired vancomycin resistance in clinically relevant pathogens.
@en
Acquired vancomycin resistance in clinically relevant pathogens.
@nl
prefLabel
Acquired vancomycin resistance in clinically relevant pathogens.
@en
Acquired vancomycin resistance in clinically relevant pathogens.
@nl
P2093
P2860
P356
P1433
P1476
Acquired vancomycin resistance in clinically relevant pathogens.
@en
P2093
Birgit Strommenger
Guido Werner
Wolfgang Witte
P2860
P304
P356
10.2217/17460913.3.5.547
P577
2008-10-01T00:00:00Z